Telomeres and telomerase as novel drug targets: reflections on the 2009 Nobel Prize in Physiology or Medicine Meng DongThomas E. MürdterUlrich Klotz Editorial 21 November 2009 Pages: 1 - 3
HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory Antonio DragoSilvia AlboniAlessandro Serretti Review Article 07 October 2009 Pages: 5 - 27
Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy Morten A. KarsdalInger ByrjalsenClaus Christiansen Clinical Trial 08 October 2009 Pages: 29 - 37
Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency Jan RegnstromFranz KoenigSpiros Vamvakas Special Article 20 November 2009 Pages: 39 - 48
The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials Mao Mao AnZui ZouYuan Ying Jiang Pharmacodynamics 21 November 2009 Pages: 49 - 59
CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients Wei ZhangYan-Zi ChangJie Zhang Pharmacogenetics 26 September 2009 Pages: 61 - 66
Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis Julian JenkinsDaphne WilliamsValerie S. Kitchen Pharmacokinetics and Disposition 16 September 2009 Pages: 67 - 76
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months John T. MondickBrendan M. JohnsonJ. Frank Hoke Pharmacokinetics and Disposition 02 October 2009 Pages: 77 - 86
Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis Antje NeubertKristin LukasWolfgang Rascher Pharmacoepidemiology and Prescription 16 September 2009 Pages: 87 - 95
Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study Terhi LauniainenAntti SajantilaIlkka Ojanperä Pharmacoepidemiology and Prescription 25 September 2009 Pages: 97 - 103
Erratum to: HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory Antonio DragoSilvia AlboniAlessandro Serretti Erratum 18 November 2009 Pages: 105 - 105
Pharmacogenomic adaptation of antiretroviral therapy: overcoming the failure of lopinavir in an African infant with CYP2D6 ultrarapid metabolism Matthias GornyStephanie RöhmTim Niehues Letter to the Editors 20 November 2009 Pages: 107 - 108